Scientific consulting firm Exponent (NASDAQ:EXPO) announced in Q1 CY2025, but sales were flat year on year at $137.4 million. On the other hand, next quarter’s revenue guidance of $130 million was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results